FDA Warning Letter — CURRAX PHARMACEUTICALS LLC

Case 610942 — FEI 3015694227

The FDA took a Warning Letter action against CURRAX PHARMACEUTICALS LLC on Sep 22, 2020 (Morristown, NJ). The action was issued by CDER and concerns drugs products.

Action details

Facility
CURRAX PHARMACEUTICALS LLC
Date
Sep 22, 2020
Fiscal Year
2020
Product Type
Drugs
Center
CDER
Location
Morristown, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.